Cytokinetics Inc
CYTK
Market Cap$4.23B
Close$
$-12.32
124.8% downside
Current Fair Value
124.8% downsideOvervalued by 124.8% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $4.23 Billion |
|---|---|
| Enterprise Value | $5.01 Billion |
| Dividend Yield | $- (-) |
| Earnings per Share | $-5.26 |
| Beta | 0.65 |
| Outstanding Shares | 119,457,000 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -6.96 |
|---|---|
| PEG | 111.49 |
| Price to Sales | - |
| Price to Book Ratio | -12.44 |
| Enterprise Value to Revenue | 58.46 |
| Enterprise Value to EBIT | -9.74 |
| Enterprise Value to Net Income | -9 |
| Total Debt to Enterprise | 0.17 |
| Debt to Equity | -2.33 |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About Cytokinetics Inc
CEO: Robert Blum